Login / Signup
NEJM at ESMO - Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors.
Eric J Rubin
Oladapo O Yeku
Stephen Morrissey
Published in:
The New England journal of medicine (2024)
Keyphrases
</>
neuroendocrine tumors
metastatic renal cell carcinoma